Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	196.58	79.38	57.26	80.93	178.27	305.74
Cash & Short-Term Investments	196.58	79.38	57.26	80.93	178.27	305.74
Cash Growth	164.26%	38.63%	-29.24%	-54.60%	-41.69%	31.02%
Accounts Receivable	36.25	29.78	10.23	15.22	28.21	23.11
Other Receivables	0.51	0.16	0.17	0.17	0.14	0.68
Receivables	36.75	29.94	10.4	15.39	28.35	23.79
Inventory	8.16	9.62	14.43	10.21	14.16	9.86
Prepaid Expenses	4.02	4.9	7.11	10.5	9.66	7.07
Other Current Assets	-	-	1.17	-	-	-
Total Current Assets	245.51	123.84	90.37	117.02	230.43	346.46
Property, Plant & Equipment	13.77	14.82	17.12	23.5	33.01	34.07
Long-Term Investments	29.45	17.66	2.59	-	-	-
Other Intangible Assets	25.51	27.61	31.86	20.29	27.2	12.55
Other Long-Term Assets	2.48	1.62	2.28	6.72	3.66	3.42
Total Assets	316.72	185.55	144.22	167.53	294.3	396.5

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	11.86	14.24	31.64	34.81	57.24	47.43
Accrued Expenses	34.54	30.71	30.74	34.68	36.51	39.99
Short-Term Debt	-	-	-	3.93	5	0.81
Current Portion of Long-Term Debt	5	-	0.63	3	7.24	4.51
Current Portion of Leases	2.25	2.13	2.62	2.52	2.45	2.1
Current Income Taxes Payable	5.18	0.36	0.93	0.84	0.72	0.35
Current Unearned Revenue	-	-	-	-	-	2.61
Other Current Liabilities	3.2	2.31	4.84	5.13	18.55	3.24
Total Current Liabilities	62.02	49.74	71.4	84.91	127.72	101.04
Long-Term Debt	34.6	52.42	57.96	60.86	93.14	46.56
Long-Term Leases	11.47	12.67	14.75	18.28	21.57	20.99
Other Long-Term Liabilities	2.54	8.53	1.76	1.89	1.85	2.03
Total Liabilities	110.63	123.37	145.87	165.94	244.28	170.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.02	0.01	0.1
Additional Paid-In Capital	788.25	783.89	763.57	717.4	675.94	656.03
Retained Earnings	-624.15	-734.05	-740.87	-694.87	-634.23	-547.46
Total Common Equity	164.14	49.87	22.73	22.54	41.72	108.67
Minority Interest	41.95	12.31	-24.38	-20.96	8.3	117.2
Shareholders' Equity	206.09	62.18	-1.64	1.59	50.03	225.88
Total Liabilities & Equity	316.72	185.55	144.22	167.53	294.3	396.5

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	53.32	67.22	75.96	88.59	129.4	74.98
Net Cash (Debt)	143.26	12.17	-18.7	-7.67	48.87	230.77
Net Cash Growth	2672.60%	-	-	-	-78.82%	59.95%
Net Cash Per Share	4.50	0.44	-0.90	-0.95	8.25	42.37
Filing Date Shares Outstanding	33.35	32.2	29.53	19.23	8.65	6.97
Total Common Shares Outstanding	33.31	31.36	27.91	15.09	7.37	6.76
Working Capital	183.49	74.1	18.97	32.11	102.72	245.42
Book Value Per Share	4.93	1.59	0.81	1.49	5.66	16.07
Tangible Book Value	138.63	22.27	-9.13	2.25	14.52	96.12
Tangible Book Value Per Share	4.16	0.71	-0.33	0.15	1.97	14.21
Buildings	0.58	0.58	0.58	0.58	0.58	0.58
Machinery	1.03	1.61	1.61	1.61	10.76	8.68
Construction In Progress	-	-	-	0.03	0.95	2.03
Leasehold Improvements	3.33	3.29	11	13.18	13.18	13.18

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error